Neonatal osteofibrous dysplasia associated with pathological tibia fracture: a case report and review of the literature

• Published in: Journal of pediatric orthopaedics. B Vol. 21; no. 2; p. 183
• Main Authors: Çetinkaya, Merih, Özkan, Hilal, Köksal, Nilgün, Sarısözen, Bartu, Yazıcı, Zeynep
• Format: Journal Article
• Language: English
• Published: United States 01.03.2012
• Subjects: Amikacin - therapeutic use; Anti-Bacterial Agents - therapeutic use; Casts, Surgical; Cefotaxime - therapeutic use; Clindamycin - therapeutic use; Fibrous Dysplasia of Bone - complications; Fibrous Dysplasia of Bone - pathology; Humans; Infant, Newborn; Infant, Newborn, Diseases - drug therapy; Infant, Newborn, Diseases - pathology; Male; Sepsis - complications; Sepsis - drug therapy; Sepsis - pathology; Tibia - pathology; Tibial Fractures - complications; Tibial Fractures - pathology; Tibial Fractures - therapy; Treatment Outcome
• ISSN: 1473-5865
• DOI: 10.1097/BPB.0b013e328344fd41

Osteofibrous dysplasia is a rare and benign disease that originates from the tibia or fibula. The symptoms of osteofibrous dysplasia include painless enlargement and bowing of the tibia and pain occurring in the presence of pathological fracture. Herein a male infant who was admitted with redness and swelling on the right leg and diagnosed as pathological tibia fracture due to left tibia osteofibrous dysplasia on the third day of life was presented. To our knowledge, this is the earliest presentation of osteofibrous dysplasia with a pathological fracture in a neonate. Therefore, it must be suspected in neonatal bone fractures.